Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-36161523

ABSTRACT

Neglected tropical diseases (NTDs) remain major public health problems in developing countries. Reducing the burden of NTDs requires sustained collaborative drug discovery efforts to achieve the goals of the new NTDs roadmap launched by the World Health Organization. Oral drugs are the most convenient choice and usually the safest and least expensive. However, the oral use of some drugs for NTDs treatment has many drawbacks, including toxicity, adverse reactions, drug resistance, drug low solubility, and bioavailability. Since there is an imperative need for novel and more effective drugs to treat the various NTDs, in recent years, several compound-loaded nanoparticles have been prepared with the objective of evaluating their application as an oral drug delivery system for the treatment of NTDs. This review focuses on the various types of nanoparticle drug delivery systems that have been recently used against the major NTDs caused by parasites such as leishmaniasis, Chagas disease, and schistosomiasis. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease.


Subject(s)
Leishmaniasis , Tropical Medicine , Humans , Drug Discovery , Leishmaniasis/drug therapy , Neglected Diseases/drug therapy , Drug Resistance
2.
J Photochem Photobiol B ; 204: 111808, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32006892

ABSTRACT

Photodynamic therapy (PDT) is effective in the treatment of different types of cancer, such as basal cell carcinoma and other superficial cancers. However, improvements in photosensitizer delivery are still needed, and the use of PDT against more deeply located tumors has been the subject of many studies. Thus, the goal of this study was to evaluate the efficacy of a nanoemulsion containing aluminium-phthalocyanine (AlPc-NE) as a mediator of photodynamic therapy (PDT-AlPc-NE) against grafted 4T1 breast adenocarcinoma tumors in mice (BALB/c). Short after the appearance of the tumor, the animals were divided into groups (n = 5) as follows: untreated; only AlPc-NE and treated with PDT-AlPc-NE. The tumor volume was measured with a digital calliper at specific times. The presence of metastasis in the lungs was evaluated by microtomography and histopathological analyses. The results show that the application of PDT-AlPc-NE eradicated the transplanted tumors in all the treated animals, while the animals from control groups presented a robust increase in the tumor volume. Still more significantly, microtomography showed the animals submitted the PDT-AlPc-NE to be free of detectable metastasis in the lungs. The histological analysis of the lungs further confirmed the results verified by the microtomography. Therefore, this study suggests that PDT-AlPc-NE is effective in the elimination of experimentally grafted breast tumors in mice and also in preventing the formation of metastasis in the lungs.


Subject(s)
Adenocarcinoma/drug therapy , Aluminum/chemistry , Breast Neoplasms/drug therapy , Indoles/chemistry , Lung Neoplasms/drug therapy , Nanostructures/chemistry , Photosensitizing Agents/therapeutic use , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/pathology , Animals , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/pathology , Cell Line, Tumor , Cell Survival/drug effects , Female , Isoindoles , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/secondary , Mice , Mice, Inbred BALB C , Nanostructures/therapeutic use , Nanostructures/toxicity , Photochemotherapy , Photosensitizing Agents/chemistry , Photosensitizing Agents/toxicity , Reactive Oxygen Species/metabolism , Transplantation, Homologous , X-Ray Microtomography
3.
J Nanosci Nanotechnol ; 20(3): 1454-1462, 2020 03 01.
Article in English | MEDLINE | ID: mdl-31492307

ABSTRACT

Even though nanotechnology has revolutionized the biomedical research, a plethora of studies debate the nanoparticles safety. In order to contribute to these studies, we evaluated the cytotoxic and epigenetic effects of maghemite nanoparticles covered with citric acid on human submandibular gland cells. Objective: This work objective was to evaluate the cytotoxic effects and epigenetic alterations induced in human salivary gland cells after treatment with maghemite nanoparticles covered with citric acid. Methods: For that, human submandibular gland cells were cultured and treated with nanoparticles for 24 or 48 hours. To assess cytotoxicity we used lactate dehydrogenase, a general oxidative stress indicator assay and microscopy. Epigenetic status was detected by colorimetric assays and the results were confirmed by quantitative polymerase chain reaction. Results: No cytotoxic effects were detected on cells exposed to up 3.0 mgFemL-1 for 48 hours, although cytoplasmic vacuoles formation was detected by light microscopy analyses. An increased generation of reactive oxygen species in cells exposed to nanoparticles was evidenced and iron clusters accumulated in the cytoplasm of treated cells. Global DNA methylation and histones H3 and H4 acetylation were also altered in response to nanoparticles exposure, thus suggesting a reprogramming of the epigenome. Transcripts accumulation analyses showed that genes related to iron metabolism and oxidative stress were upregulated, while the gene related to epigenetic reprogramming presented reduced transcript accumulation after treatment. Conclusion: We concluded that maghemite nanoparticles covered with citric acid exposure provoked several biological responses without impairment of human submandibular gland cells viability. This is the first report on the epigenetic effects of maghemite nanoparticles on this cell lineage.


Subject(s)
Magnetic Iron Oxide Nanoparticles , Nanoparticles , Epigenesis, Genetic , Humans , Nanoparticles/toxicity , Oxidative Stress/genetics , Reactive Oxygen Species/metabolism , Submandibular Gland/metabolism
4.
Photodiagnosis Photodyn Ther ; 27: 39-43, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31125768

ABSTRACT

Cutaneous hemangiosarcoma is a malignant neoplasia that frequently occurs in dogs. The most effective treatment requires wide surgical excision of the tumor. To avoid mutilating surgeries, photodynamic therapy (PDT) could serve as an alternative treatment. This study aimed to treat cutaneous hemangiosarcomas in dogs using PDT with aluminium-chloride-phthalocyanine nanoemulsion (AlClPc-nano) as photosensitizer. Eight dogs with histopathological diagnosis of naturally occurring cutaneous hemangiosarcoma were treated. Animals were given intra and peritumoral injections of AlClPc-nano (13.3 µM). After 15 min, the masses were LED irradiated at a wavelength of 658-662 nm (80 mW potency) for 25 min (120 J/cm2 fluency). The number of sessions was based on lesion observations, with PDT sessions repeated every 7 days until the mass was no longer macroscopically visible. On that occasion, an excisional biopsy of the area was taken for histopathology analysis. Blood was collected from each animal before each PDT session and excisional biopsy for hematological analysis (blood counts; liver and kidney function). The number of PDT sessions varied from 2 to 4, depending on the size of the initial mass. Seven of the eight cases demonstrated complete remission of neoplasia. Microscopic analysis of the excisional biopsies showed necrosis and hemorrhage only, with no cancer cells, except in one case. During the treatment, inflammation and necrosis were macroscopically observed in the treated areas. The dogs did not show any alteration in blood parameters that could be related to the PDT. In conclusion, PDT with AlClPc-nano is a safe and effective treatment for cutaneous hemangiosarcoma in dogs.


Subject(s)
Emulsions/therapeutic use , Hemangiosarcoma/veterinary , Photochemotherapy/veterinary , Photosensitizing Agents/therapeutic use , Skin Neoplasms/veterinary , Aluminum Compounds/therapeutic use , Animals , Chlorine Compounds/therapeutic use , Dogs , Emulsions/adverse effects , Emulsions/chemistry , Female , Hemangiosarcoma/drug therapy , Hemangiosarcoma/pathology , Indoles/therapeutic use , Isoindoles , Male , Nanoparticles/chemistry , Photochemotherapy/adverse effects , Photochemotherapy/methods , Photosensitizing Agents/adverse effects , Skin Neoplasms/drug therapy , Skin Neoplasms/pathology
5.
J Nutr Biochem ; 25(11): 1161-1176, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25127291

ABSTRACT

The development of therapeutic strategies to attenuate chemotherapy toxicity represents an area of great interest in cancer research, and among them is nutritional therapy based on antioxidants. As research on this topic is still controversial and scarce, we aim to investigate the effects of antioxidant supplementation with vitamin C, vitamin E or pequi oil, a carotenoid-rich oil extracted from pequi (Caryocar brasiliense), on doxorubicin (DX)-induced oxidative damage to normal cells in Ehrlich solid tumor-bearing mice. Tumor weight and volume, histopathology, morphometry and immunohistochemistry were used to assess the treatments' efficacy in containing tumor aggressiveness and regression, while possible toxicity of treatments was assessed by animals' weight, morphological analysis of the heart, liver and kidneys, hemogram, and serum levels of total bilirubin, direct bilirubin, indirect bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamyl transferase (GGT), alkaline phosphatase, creatinine and urea. Although all the chemotherapeutic treatments increased internal necrosis area and reduced the positive Ki-67 cells compared to non-treated tumors, the treatments with pequi oil provided before tumor inoculation (PTDX) or in continuous and concurrent administration with doxorubicin (PTPDX) were more effective in containing tumor growth, besides increasing lymphocyte-dependent immunity and reducing the adverse side effects associated with DX-induced oxidative damage to normal cells, mainly the PTDX treatment. Vitamins C and E given before tumor inoculation and chemotherapy were not successful against doxorubicin-induced cardiotoxicity, besides increasing doxorubicin-induced nephrotoxicity, indicating that, at least for doxorubicin, pequi oil instead of vitamins C and E would be the best option to reduce its adverse effects.


Subject(s)
Antibiotics, Antineoplastic/toxicity , Carcinoma, Ehrlich Tumor/drug therapy , Carotenoids/analysis , Doxorubicin/toxicity , Plant Oils/chemistry , Animals , Antibiotics, Antineoplastic/therapeutic use , Ascorbic Acid/analysis , Carcinoma, Ehrlich Tumor/metabolism , Carcinoma, Ehrlich Tumor/pathology , Doxorubicin/therapeutic use , Female , Mice , Oxidative Stress/drug effects , Plant Oils/pharmacology , Vitamin E/analysis
6.
J Biomed Nanotechnol ; 8(2): 251-7, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22515076

ABSTRACT

Breast tumors represent the most common malignant tumors. Current treatments for humans and pets rely on tumor excision and adjuvant chemotherapy, which may affect both cancer cells and normal cells. Photodynamic therapy (PDT) is an approved treatment modality for a variety of cancers and was recently recommended as a first-line treatment for non-melanoma skin cancers for humans. The main purpose of the present study was to determine the efficacy of PDT using aluminum-chloride-phthalocyanine that is encapsulated in liposomes and LED as a light source to kill naturally occurring female dog breast cancer in vitro. The cytotoxicity behavior of the encapsulated photosensitizer in the dark and under irradiation using the 670 nm laser were investigated using classical trypan blue and MTT cell viability tests, acridine orange and ethidium bromide staining to label organelles, and cell morphology. Cell morphology was evaluated using light and electron microscopy. Our results demonstrate a reduced cell viability that is associated with morphologic alterations. The neoplasic cell destruction was predominantly mediated via a necrotic process, which was assayed using acridine orange and ethidium bromide staining. These findings were confirmed using light and electronic microscopy. The photosensitizer or laser irradiation alone did not induce cytotoxicity or morphological alterations, indicating the safety and efficacy of PDT with chloro-aluminum-phthalocyanine that was encapsulated in liposomes for the treatment of breast cancer cells in vitro.


Subject(s)
Indoles/pharmacology , Liposomes/pharmacology , Mammary Neoplasms, Animal/drug therapy , Organometallic Compounds/pharmacology , Photochemotherapy/methods , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cell Survival/drug effects , Dogs , Female , Indoles/chemistry , Liposomes/chemistry , Mammary Neoplasms, Animal/pathology , Mice , Microscopy, Electron, Transmission , Microscopy, Phase-Contrast , NIH 3T3 Cells , Necrosis , Organometallic Compounds/chemistry , Photosensitizing Agents/chemistry , Photosensitizing Agents/pharmacology , Tumor Cells, Cultured
7.
Lasers Med Sci ; 27(3): 575-84, 2012 May.
Article in English | MEDLINE | ID: mdl-21809069

ABSTRACT

Photodynamic therapy (PDT) is a technique employed in the treatment of several superficial infections, such as caries. PDT uses a non-toxic drug termed photosensitizer (PS) followed by light irradiation. The cytotoxic effects of the therapy are related to the production of reactive species produced after light activation of a photosensitizer, which reacts with surrounding molecules and disrupts several of the cell's functions. Within this context, this study aimed to develop a clinical protocol involving PDT application mediated by aluminum-chloride-phthalocyanine (AlClPc) entrapped in cationic liposomes against cariogenic bacteria in caries lesions. Cationic liposomes were used to delivery AlClPc preferentially to bacterial cells due to the strong anionic superficial charges of these cell types. The results are represented in two fundamental steps: (1) in vitro evaluation of AlClPc delivery to cariogenic bacteria and pulp cells, as well as its potential phototoxicity; (2) a clinical study involving volunteer patients that were treated with the PDT protocol mediated by AlClPc-cationic liposome. The main results showed that the AlClPc-cationic liposome was preferentially absorbed by bacterial cells compared to eukaryotic dental pulp cells, and it was efficient in the reduction of microbial load from bacterial cultures. In addition, the clinical study showed a mean reduction of 82% of total bacterial in the treated cavities after PDT application. Taken together, the results presented in this study showed that the antimicrobial PDT protocol mediated by cationic liposomes containing AlClPc is safety for clinical application and is efficient in the reduction of bacterial load in caries lesions.


Subject(s)
Dental Caries/therapy , Disinfection/methods , Photochemotherapy/methods , Adult , Animals , Bacterial Load , Cations , Cells, Cultured , Child , Chlorides , Clinical Protocols , Dental Caries/microbiology , Dental Cavity Preparation/methods , Dental Pulp/cytology , Dental Pulp/drug effects , Humans , In Vitro Techniques , Indoles/therapeutic use , Liposomes , Mice , NIH 3T3 Cells , Organometallic Compounds/therapeutic use , Photosensitizing Agents/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...